Hadasit Bio Cash Flow-to-Debt Ratio
Hadasit Bio cash flow-to-debt ratio. Hadasit Bio (HDST) has a Cash Flow-to-Debt Ratio of -0.33x as of June 2022, meaning its operating cash flow of ILA-360.50K could theoretically repay 0% of its total liabilities (ILA1.10 Million) in one year. Check HDST cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hadasit Bio (2013–2022)
Cash flow-to-debt ratio of Hadasit Bio from 2013 to 2022. Historical debt coverage capacity for Hadasit Bio across 10 annual periods. Also explore Hadasit Bio (HDST) net asset momentum to track the company's year-over-year net asset growth rate.
Hadasit Bio Cash Flow-to-Debt Ratio by Year (2013–2022)
Hadasit Bio cash flow-to-debt ratio by year from 2013 to 2022. Year-by-year debt coverage analysis for Hadasit Bio. For the full cash flow conversion analysis, see Hadasit Bio cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.55x | ILA-2.12 Million | ILA3.88 Million | ▲ +81.2% |
| 2021 | -2.91x | ILA-2.10 Million | ILA722.00K | ▼ -213.7% |
| 2020 | -0.93x | ILA-3.96 Million | ILA4.27 Million | ▼ -14.1% |
| 2019 | -0.81x | ILA-3.18 Million | ILA3.91 Million | ▲ +94.9% |
| 2018 | -15.93x | ILA-16.46 Million | ILA1.03 Million | ▼ -608.0% |
| 2017 | -2.25x | ILA-17.57 Million | ILA7.81 Million | ▼ -20.1% |
| 2016 | -1.87x | ILA-14.68 Million | ILA7.84 Million | ▼ -17.4% |
| 2015 | -1.60x | ILA-13.26 Million | ILA8.31 Million | ▼ -34.3% |
| 2014 | -1.19x | ILA-12.24 Million | ILA10.31 Million | ▼ -1.0% |
| 2013 | -1.18x | ILA-11.61 Million | ILA9.87 Million | — |